Rosler_1999_BMJ_318_633

Reference

Title : Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial - Rosler_1999_BMJ_318_633
Author(s) : Rosler M , Anand R , Cicin-Sain A , Gauthier S , Agid Y , Dal-Bianco P , Stahelin HB , Hartman R , Gharabawi M
Ref : BMJ , 318 :633 , 1999
Abstract : Rosler_1999_BMJ_318_633
ESTHER : Rosler_1999_BMJ_318_633
PubMedSearch : Rosler_1999_BMJ_318_633
PubMedID: 10066203

Related information

Citations formats

Rosler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stahelin HB, Hartman R, Gharabawi M (1999)
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial
BMJ 318 :633

Rosler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stahelin HB, Hartman R, Gharabawi M (1999)
BMJ 318 :633